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Introduction
Prostate cancer (PrCA) is the most common form of cancer and the second leading cause of
cancer deaths among U.S. men, with an estimated 218,890 new cases and 27,050 deaths
from it in the U.S. in 2007.1 Since 1995 incidence has increased by 1% annually while
PrCA mortality has decreased by 4%.2 Despite this somewhat favorable trend, African
American (AA) men remain at significantly greater risk of PrCA than men of other racial
groups, with age-adjusted incidence and mortality rates of 258.3 and 64.0 per 100,000 men,
contrasting with respective rates of 163.4 and 26.2 for Caucasian (C) men between 2000 and
2003.3 In North Carolina, this disparity is among the broadest in the nation, with AA men
experiencing PrCA mortality nearly three times greater than that of C men (76.2 vs. 26.4 per
100,000, respectively).4 Many factors may contribute to these disparities, including
differences in proactive health behaviors such as utilization of PrCA screening.5 However, a
large portion of this difference remains unclear because the relevant characteristics and
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issues driving health behaviors are so tightly intertwined; thus, design of effective
interventions to improve health behaviors and screening rates continues to be challenging.
PrCA screening, though controversial, can detect PrCA many years before a patient would
present with symptoms.5-9 Compared to clinically-detected (e.g., symptomatic) PrCA,
screening-detected cancers are predominantly early disease, for which the prognosis is
considerably better than that of clinically-detected PrCA.7,10 Although PrCA screening
allows for detection of disease at an earlier course, the effects of early PrCA detection on
mortality rates still need to be rigorously investigated to identify quantifiable survival
benefits and minimize the influence of lead-time and length-time biases.11
Regardless, many recommend screening 12,13 Men with a known family history of PrCA
have demonstrated heightened perceived vulnerability to PrCA, which has predicted
screening behavior.14,15 When present, knowledge of risk may only translate into
information seeking behavior, and not into proactive health behaviors such as regular
checkups and screenings.16,17 Many men with a family history of PrCA are unaware of
their heightened risk or underestimate it. 15,17-19 Specifically, AA men have been shown to
be less likely to appreciate family history and other prostate risk cancer factors than C men.
18,20
Given that AA men are diagnosed with more advanced PrCA than C men and have a
demonstrated lower awareness of PrCA risk factors, improvement of risk awareness among
AAs merits exploration as a point of intervention that may contribute to enhanced utilization
of screening, consequent detection at an earlier, more treatable stage, and a potential
reduction in racial differences in PrCA mortality. Studies addressing whether differences in
awareness of risk or reduced tendency to act on knowledge of risk contribute to the
disparities in the stage of PrCA diagnosis are scant. We therefore employed a questionnaire
designed to disentangle the constituent elements commonly associated with race,
socioeconomic status, and drivers of health care utilization to study a population of AA and
C men newly diagnosed with PrCA. We describe racial differences in perceived risk of
PrCA and examine (a) whether perceived high risk for PrCA translates into greater personal
responsibility for prostate care, and (b) whether in turn greater personal responsibility for
prostate care translates into earlier, pre-symptomatic PrCA diagnosis.
Conceptual Model and Hypotheses
The Health Belief Model postulates that an individual will act if he perceives himself to be
susceptible to a health threat, but that perceived barriers may deter action.21 In this study,
we hypothesize that men with a first degree relative who had PrCA will perceive themselves
at higher risk, which will produce greater personal responsibility for their prostate health and
proactive actions including getting screened. Further, we hypothesize that increased personal
responsibility for prostate health will increase asymtomatic diagnosis. Finally, we
hypothesize that barriers such as access to care, physician trust, and avoidance behaviors
will affect the relationships between perceived risk, action, and mode of diagnosis.
METHODS
Sample
The study sample consisted of 555 Caucasian (C) and African American (AA) men newly
diagnosed with PrCA between November 2001 and May 2004 who agreed to be surveyed.
We excluded men who identified their race one other than C or AA. Figure 1 illustrates the
method of sample derivation. Details of the patient population, sample derivation,
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questionnaire, and data collection methods have been published elsewhere.22 The following
measures were used for the analyses described herein.
Demographics
Self-reported study demographics included patient race, age at diagnosis, marital status
(currently married or not), education level (college graduate or not), employment status
(working or not), and whether the patient had a doctor's office (rather than a public clinic or
emergency department) as their primary source of care.
Prostate Cancer Risk
Because family history of PrCA has been identified as the strongest known risk factor15,
“risk” in this study was defined as familial risk. Men were asked if any relative had been
diagnosed with PrCA, and if so, which relatives and at what age. Men were considered at
“actual high risk” if they reported a first-degree relative (father, brother, or son) having had
PrCA. For men with a first degree relative with PrCA, we asked at what age the relative was
diagnosed.
A single-item measure of perceived risk was used.15,16 Each participant was asked what he
thought his risk of getting PrCA was compared to other men: much greater than, greater
than, the same as, less than, or much less than. We considered a stated risk of at least
“greater than” other men to be a perception of high risk.
Using the above definitions for actual and perceived risk, we calculated variables for under-
or over-estimation of risk. We defined “underestimated risk” for men who had a family
history of prostate cancer but yet did not report that his risk for prostate cancer was at least
“greater than” other men. Similarly, we defined “overestimated risk” for men who did not
have a family history of prostate cancer but yet did report that his risk for prostate cancer
was “greater” (or “much greater”) than other men.
Physician Trust
For the current study, we measured patient's trust of physicians with items adopted from the
Primary Care Assessment Survey's Trust in Physician Scale.23The scale is composed of the
following items each answered on a 5-point Likert scale (α=0.77): (1) I can tell my doctor
anything, (2) My doctor sometimes pretends to know things when he is really not sure
(reverse coded), (3) I completely trust my doctor's judgments about my medical care, (4) My
doctor cares more about holding down costs than about doing what is needed for my health
(reverse coded), (5) My doctor would always tell me the truth about my health, even if it
was bad news, (6) My doctor cares as much as I do about my health, (7) If a mistake were
made in my treatment, my doctor would try to hide it from me (reverse coded), and (8) All
things considered, how much do you trust your doctor? Trust indices were standardized to a
0 – 100 scale, where higher scores indicate more trust.
Personal Responsibility for Prostate Care
We adopted the concept of “personal responsibility” from the literature on breast cancer and
the health belief factors related to screening mammography.24.25 This scale was measured
by the following items (□=0.62): (1) I have been careful to have my prostate checked
regularly, (2) I sometimes felt I should have my prostate checked but decided not to have it
done (reverse coded), (3) My prostate cancer was found mostly due to luck (reverse coded),
(4) I have had regular PSAs. As with the trust indices, responsibility indices were
standardized to a 0 – 100 scale, where higher scores indicate more responsibility for prostate
care.
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Avoidance of Prostate Checkups from Fear
A high degree of avoidance behavior was assigned to men who agreed with the statement:
Men delay getting their prostate checked from fear of what the doctor may find.
Prostate Cancer Diagnosis
Men were asked “What was the first evidence, test, or symptom that led to diagnosing your
prostate cancer?” Men were asked to choose between “abnormal PSA blood test,” “doctor
felt abnormal prostate,” “cancer found at surgery for benign prostate problem,” or “urinary
symptoms or discomfort.” Men who answered “urinary symptoms or discomfort” were
categorized as “symptomatic diagnosis” and all other men were categorized as “non-
symptomatic diagnosis.”
Statistical methods
All data manipulation and statistical analyses were performed using PC SAS 9.1.26
Frequency distributions for survey variables by race and overall were generated to profile
study participants. Bivariate analyses were conducted to assess racial differences in all
sociodemographic, risk perception, and health belief variables. Satterthwaite t-tests with
unequal variances for continuous variables and 2 × n □2 statistic or generalized Fisher's
exact test for categorical variables were used for all bivariate analyses. Subsequently,
multivariate logistic regression was performed using the general linear modeling procedures.
Three multivariate models, each with distinct binomial outcomes and controlling for all
other sociodemographic, risk perception, and health belief variables, were examined:
Model 1: Outcome = Perceived high risk for PrCA.
Model 2: Outcome = Personal responsibility for prostate care.
Model 3: Outcome = Symptoms at first evidence of PrCA.
When the outcome event is common (incidence of 10% or more), relative risk (RR)
estimates are preferred over odds ratios (OR) because of the increasing differential between
the RR and OR with increasing incidence rates.27,28 Because the three outcome variables
had incidence rates in our sample at greater than 10%, we used the SAS GENMOD
procedure, specifying a binomial distribution and log link, in order to get relative risk
estimates for predictor variables in each of the three models. For a given model, the relative
risk generated for each variable indicates the difference in magnitude of the likelihood of the
outcome between levels of the variable.
Results
Table 1 shows the bivariate comparison of C and AA men in terms of demographics, clinical
measures, prostate cancer risk, and health beliefs and attitudes. AA men in our study were
diagnosed, on average, 2.5 years younger than C men. Although equally likely to be
currently employed, AA men were less often married, less often college graduates (both
p<0.01), and less likely to receive primary care in a doctor's office (71.5% versus 86.2%, p<.
001). While more often reporting first degree relatives with PrCA (30.4% vs. 21%, p<.01),
AA men were no more likely to perceive themselves to be at higher risk. The age at PrCA
diagnosis was lower in AA men's family histories-- 30% of AA men's relatives were
diagnosed before the age of 60, compared to 12% of C men's relatives (p<.05). AA men
estimated their risk less accurately than C men in both directions, underestimating their
PrCA risk when they had a first degree relative with PrCA (18.8% vs. 9.8%, p<.05), and
overestimating when they did not (11.1% vs. 7.2%, p<.01).
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AA men had significantly lower mean physician trust scores than white men (86.1% vs.
89.8%, p<.01) and significantly lower mean responsibility scores than C men (69.7% vs.
83.9%, p<.01). Furthermore, almost 75% of AA respondents (compared to 57% of C men)
indicated that they were likely to avoid getting their prostate checked for fear of what the
doctor may find (p<.01). Screening in fact played a lesser role for AA respondents.
Compared with C men, a larger proportion of AA men indicated that symptoms were their
first evidence of PrCA (34.3% for AA vs. 24.4% for C, p<.01).
Table 2 shows the multivariate analyses results. For each of these analyses, all independent
variables were entered into the models together (rather than in a stepwise fashion).
Model 1: Perceived high risk for prostate cancer
Multivariate analyses showed that when controlling for age, race, and other socio-
demographic factors as well as health beliefs and attitudes, men with a first degree relative
with PrCA were over twice as likely to perceive themselves to be at higher risk for PrCA
than other men like themselves (p<.05), and having a relative diagnosed at a young age
additionally increased the perception of high risk by 41% (both p<.05). In this adjusted
model, race was not a significant predictor of risk perception, nor was age, marital status,
health care source, or any health beliefs and attitudes.
Model 2. Personal responsibility for prostate care
Men who were married, college graduates and who had higher physician trust scores more
often took personal responsibility for the care of their prostate (p<.05) In this adjusted
model, race, age, actual PrCA risk, and perceived PrCA risk did not significantly predict the
acceptance of personal responsibility for prostate care.
Model 3. Diagnosed symptomatically
Men who received primary care in a doctor's office, rather than an ER or clinic, were less
likely have their PrCA detected by symptoms, rather than screening, as were men who
expressed high personal responsibility for their cancer care (p<.05). Age was not a
significant predictor of symptomatic diagnosis. Similarly, neither race, actual PrCA risk, nor
perceived PrCA risk, were significant predictors after adjusting for other variables.
Discussion
Future efforts designed to reduce the racial disparity in prostate cancer outcomes should
continue to educate men of their prostate cancer risk while at the same time encouraging
further action and preventive behaviors, as this study found that risk perception did not
predict screening behavior. Rather, future research could incorporate interventions designed
to empower men to be personally responsible for their prostate health, including having
regular prostate checks and not delaying check ups due to fear or fatalistic attitudes. Results
described herein seem to indicate that merely understanding that one is at greater risk for
prostate cancer is not enough.
Furthermore, because we found that risk does not predict behavior, but that physician trust
does, research as well as clinical efforts could be made towards increasing AA's trust in
physicians and ultimately strengthening the physician-patient relationship. Physician trust
has been associated with willingness to seek care29, and the use of medical services by AA
men, potentially reducing both their historically unequal treatment and current health
disparities.30 In our multivariate analysis, lower physician trust predicted reduced likelihood
to take active steps towards regular prostate exams. This indicates that the racial differences
in seeking prostate care may be mediated in part through reduced trust. However, we found
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evidence consistent with our observation elsewhere that reduced trust, in turn, arises from
limited opportunities to establish a longitudinal relation with a physician.22 Therefore,
future research efforts must address the causal relationship between trust and access, as well
as address the reduced access to regular physicians in AA men as access to care is most
likely a significant predictor of preventive and screening behaviors.
Our study has limitations. Other than stage at diagnosis, all data are self-reported, which
opens the possibility of recall bias. As reported in our previous study22, patients' recall
regarding checkups and PSA usage may be inaccurate and influenced by subsequent events
such as patient care and treatment. Further, long term outcomes are unavailable at this time,
so we were unable to examine associations between the mode of diagnosis to PrCA
mortality and other adverse events. In addition, the cross-sectional design limits conclusions
regarding causation, and future longitudinal studies are warranted to more accurately assess
the relationship among risk, behavior, trust, symptomatic diagnosis, and later outcomes.
The study focused on the perception of increased risk of PrCA from a history of PrCA in a
first-degree relative. AA men, however, may have considered themselves at greater than
average risk because of their race. If AA men factored in race as a risk factor for PrCA as
well as family history, we would predict that AA men would overestimate their PrCA risk
more and underestimate their risk less than their C counterparts. However, AA men both
overestimated and underestimated their relative PrCA risk more frequently than C men,
suggesting that the perception of race as a risk factor may not have been a major factor in
their self-assessment of PrCA risk. Still, the opportunity for misclassification of PrCA risk
among at least some AA men is a limitation for drawing conclusions from this study's
results.
The importance of our study lies in the finding that the disproportionate number of AA men
who are already symptomatic at the time of PrCA diagnosis arises not from less
responsibility for prostate care due to inaccurate risk perceptions, rather from the racial
disparity in access to a regular physician and physician trust, which ultimately leads fewer
AA men to seek prostate care or screenings. Our results have a major implication:
perception of risk, taking active responsibility for prostate care, regular access to a
physician, and trust are related in a complex way. We hope that this study addresses some of
the factors that contribute to the racial disparity in PrCA outcomes.
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Figure 1.
Determination of study sample.
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Table 1
Socio-demographics and health-related factors of a sample of men newly diagnosed with prostate cancer
(n=555).
Study Variables White(n=348)
Black
(n=207)
Total
Sample
(n=555)
Demographics
Diagnosis Age
 40 to 49 7 (2.0)** 13 (6.3) 20 (3.6)
 50 to 59 92 (26.4)# 70 (33.8) 162 (29.2)
 60 to 69 158 (45.4) 90 (43.5) 248 (44.7)
 70 + 91 (26.1)** 34 (16.4) 125 (22.5)
 Mean diagnosis age 64.5** 61.9 63.5
Married 303 (87.1)** 148 (71.5) 451 (81.3)
College Graduate 158 (45.4)** 33 (15.9) 191 (34.4)
Employed 167 (48.0) 94 (45.4) 261 (47.0)
Primary place for healthcare
 Doctor's Office 300 (86.2)** 148 (71.5) 448 (80.7)
 ER / Public Clinic 48 (13.8) 59 (28.5) 107 (19.3)
Cancer Diagnosis
AJCC Cancer Stage
 I 1 (0.29) 1 (0.5) 2 (0.36)
 II 267 (76.7) 164 (79.2) 431(77.7)
 III 33 (9.5) 15 (7.3) 48 (8.6)
 IV 7 (2.0) 4 (1.9) 11 (2.0)
 Not Reported 40 (11.5) 23 (11.1) 63 (11.3)
First Evidence of Cancer
 Symptomatic 85 (24.4)** 71 (34.3) 156 (28.1)
 Non-symptomatic 263 (75.6)** 136 (65.7) 399 (71.9)
Prostate Cancer Risk
Perceived High Risk 64 (18.4) 47 (22.7) 111 (20.0)
1st degree relative with PrCA 73 (21.0)** 63 (30.4) 133 (24.0)
Age Relative Diagnosed&
 < 50 years 1 (1.4%)* 5 (7.9%) 6 (1.1)
 50 – 59 years 8 (11.0%)* 14 (22.2%) 22 (4.0)
 60 – 69 years 37 (50.7%)* 21 (33.3%) 58 (10.5)
 70 + years 27 (37.0%) 23 (36.5%) 50 (9.0)
 Mean diagnosis age 67.7 65.0
% High Risk and Perceive It^ 53.4%# 38.1% 63 (11.4)
% Underestimate Risk@ 9.8%** 18.8% 73 (13.2)
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Study Variables White(n=348)
Black
(n=207)
Total
Sample
(n=555)
% Overestimate Risk+ 7.2%** 11.1% 48 (8.6)
Health Beliefs/Attitudes
Physician Trust
 < 75 30 (8.6)** 40 (19.3) 70 (12.6)
 75 to 84 41 (11.8) 21 (10.1) 62 (11.2)
 85 to 94 110 (31.6) 58 (28.0) 168 (30.3)
 95 + 167 (48.0) 88 (42.5) 255 (45.9)
Mean Physician Trust Score 89.8** 86.1 88.4
Personal Responsibility for Prostate Care
 < 60 56 (16.1)** 73 (35.3) 129 (23.2)
 60 to 74 16 (4.6) 10 (4.8) 26 (4.7)
 75 to 84 63 (18.1) 49 (23.7) 112 (20.2)
 85 to 94 28 (8.1)# 9 (4.3) 37 (6.7)
 95 + 185 (53.2)** 66 (31.9) 251 (45.2)
Mean Responsibility Score 83.9** 69.7 78.6
Likely to avoid getting prostate care due to fear 197 (56.6)** 155 (74.9) 352 (63.4)
*
p<.05
**
p<.01
#
p<.10
&
% of all men who reported a 1st degree relative with prostate cancer (n=136).
^
% of all men who had a first degree relative with PrCA (% of those at high risk)
@
% of entire sample
+
% of entire sample
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Table 2
Logistic regression results. Relationship among demographic factors, family history of prostate cancer,
perceived risk of prostate cancer, physician trust and personal responsibility for health and prostate cancer
among a sample of men newly diagnosed with prostate cancer (n=555).
Socio-demographic and
Health-Related Factors
Perceived High
Risk for
Prostate
Cancer
Personal
Responsibility
for Prostate
Care
Diagnosed
Symptomatically
Demographics
White (ref: Black) 0.85 (0.65, 1.12) 0.94 (0.81, 1.09) 0.81 (0.61, 1.08)
Diagnosis age 40 to 59 (ref: age 60+) 1.15 (1.11, 1.16) 1.02 (0.99, 1.06) 1.16 (0.85, 1.58)
Not Reported
Married 1.20 (0.87, 1.65) 1.36 (1.09, 1.70) 1.14 (0.81, 1.61)
College Graduate 1.43 (1.10, 1.87) 1.35 (1.18, 1.54) 0.78 (0.55, 1.09)
Employed 1.15 (0.87, 1.52) 0.88 (0.76, 1.02) 1.10 (0.80, 1.50)
Doctor's office as primary source of care 0.80 (0.60, 1.07) 1.12 (0.92, 1.35) 0.76 (0.56, 0.99)
Prostate Cancer Risk
1st degree relative with prostate cancer 2.56 (1.95, 3.37) 1.07 (0.90, 1.28) 0.91 (0.62, 1.32)
Perceived High Risk for prostate cancer -- 1.08 (0.93, 1.25) 0.89 (0.60, 1.30)
1st degree relative diagnosed at a young age 1.41 (1.02, 1.96) 1.04 (0.85, 1.27) 0.75 (0.53, 1.06)
Health Beliefs/Attitudes
Highly trusting of physician 0.91 (0.71, 1.17) 1.12 (1.00, 1.29) 0.90 (0.69, 1.19)
Avoids: Fearful of getting prostate checked 0.96 (0.74, 1.25) 0.97 (0.85, 1.10) 0.99 (0.74, 1.32)
Highly responsible for prostate care 1.09 (0.83, 1.41) -- 0.79 (0.60, 0.99)
Note: Cells represent odds ratio and 95% confidence limits. Odds ratios in bold and italicized are significantly different from 0 (p<.05).
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